GSK3B and lung carcinoma: These results suggest that TM4SF4-induced GSK3β/β-catenin pathway may be mediated by the activation of the receptor tyrosine kinase (RTK)-linked AKT pathway or non-RTK-linked AKT pathway in lung cancer cells.